Why does Pharmac neglect inflammatory bowel disease?

N Z Med J. 2020 Dec 18;133(1527):111-115.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / economics
  • Colitis, Ulcerative / drug therapy*
  • Crohn Disease / drug therapy*
  • Drug Approval / economics*
  • Gastrointestinal Agents / economics*
  • Government Agencies*
  • Humans
  • New Zealand
  • Ustekinumab / economics

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab
  • Ustekinumab